Integer Holdings Corporation (NYSE: ITGR), a leading global medical device contract development and manufacturing organization (CDMO), today announced that its Board of Directors (the “Board”) has ...

Integer Holdings (ITGR) launches a strategic review, weighing a sale/merger or standalone path; plus Q1 FY26 results beat on ...

Integer (NYSE:ITGR) reported first-quarter 2026 results that management said were in line with the outlook it provided in February, while also lowering its full-year forecast to reflect updated ...

Integer's shares jump despite a Q1 EPS miss and margin pressure, as revenues rise slightly Y/Y and beat estimates on strength ...

Q1 2026 earnings call recap: updated guidance, EP forecast reset, margins, and strategic review highlights—read the key takeaways.

Integer Holdings has begun a strategic review to consider a sale, merger, business combination, or continuing its standalone plan, following activist investor engagement and stronger-than-expected Q1 ...

First quarter results in line with February outlook ~~ Updates 2026 outlook ranges; continues to expect 200bps above-market organic sales ...

Integer Holdings Corp ITGR reported better-than-expected first-quarter financial results on Thursday. Integer Holdings ...

There is no deadline for the review and no assurance it will result in a transaction. Integer separately lowered its outlook for 2026, citing headwinds with three of its products.

Integer Holdings Corporation (NYSE: ITGR), a leading medical device contract development and manufacturing organization, today announced participation in the 2026 Bank of America Healthcare Conference ...

Shares of Integer (NYSE: ITGR), a company specializing in the development and manufacturing of medical devices, saw a substantial decline of 32% on October 23, 2025. This notable drop was mainly due ...